Study Suggests Flu Shot Increases Flu Risk: Negative Efficacy Discussed

Cleveland Clinic Study Findings

• 🔬 A large study from the Cleveland Clinic involving over 53,000 employees found that the influenza vaccine for the 2024-2025 season had a negative efficacy of 26.9%.
• ⚠️ This means individuals who received the flu shot were 26.9% more likely to contract influenza compared to those who were unvaccinated.
• 💡 The study's methodology is described as robust, with results adjusted for age, sex, and job type, indicating a statistically significant finding.

Negative Efficacy Explained

• 📈 The concept of "negative efficacy" is highlighted, meaning the vaccine is not only ineffective but actively increases the risk of the illness it's intended to prevent.
• 📉 A graph shows that while vaccinated and unvaccinated groups had similar initial influenza rates, the incidence increased more rapidly among the vaccinated over time.
• 🎯 The probability of this result occurring by chance was very low (seven in a thousand), suggesting the findings are reliable.

Comparison to COVID-19 Vaccine Data

• 🔄 The discussion draws parallels to a previous Cleveland Clinic study from 2023 that indicated negative efficacy for COVID-19 vaccines.
• 💉 That study suggested that the more COVID-19 vaccine doses received, the higher the cumulative incidence of COVID-19.
• 🧐 This pattern raises questions about the effectiveness and potential unintended consequences of widespread vaccination programs.

Implications and Concerns

• 🌍 The study's authors suggest the results are generalizable to relatively healthy adults in the USA, implying a broader impact beyond the study population.
• 💰 Concerns are raised about the financial implications for the pharmaceutical industry when vaccines demonstrate negative efficacy, though specific financial details were not provided in the paper.
• ⚠️ A significant concern is the potential shift towards mRNA vaccines if current inactivated virus vaccines are perceived as ineffective, a prospect viewed as "horrific" by the speaker.
• 🤔 The discussion questions the independence of regulatory agencies, suggesting their funding by the pharmaceutical industry might influence recommendations.